Corneal epithelium injury
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 8 to 65 years; 2. The patient has been prescribed appropriate overnight orthokeratology when enrolling time; 3. The corneal fluorescein staining was positive of any eye which after wearing orthokeratology; 4. The patient has not dry eye or any other ocular surface disease; 5. The patient has not any cornea refractive surgical history; 6. The patient can understand the objectives of the clinical trial, participate voluntarily and will sign the informed consent form by himself or by his/her legal guardian, and will complete the follow-up on time.
Exclusion criteria
Exclusion criteria: 1. The patient's adaptability for orthokeratology is bad, so the patient need to change the lens or stop wearing the lens under the jugement by investigator; 2. The patient with any abnomality as corneal ulcer, conjunctivitis, scleritis, uveitis, and other infective or non-infective eye disease; 3. The patient with any ocular trauma, ocular oncology, glaucoma, cataract, ocular fundus disease and other eye disease needing further treatment;; 4. The patient with serious or unstable disease in heart, liver, kidney, lung, internal secretion (including thyroid dysfunction) blood, mind dysfunction, or neurological dysfunction, etc; 5. The patient with diabetes mellitus; 6. Pregnant women or lactating women, or has pregnancy plan in the near future; 7. Not suitable of inclusion in other situation by the judgement of investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corneal fluorescein staining score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tear film break up time;subjective symptoms score; | — |
Countries
China
Contacts
Shanghai Qisheng Medical Technology Development Co., Ltd.